-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, T2lAcSZ0rs/cSV55b0yie5BklwJGFPJ9u+zoJ4OOYiRM6CEqzK8Gpl4DdwgIsKJK WisW7kYQ907KmGDlUtlqzg== 0001324517-06-000075.txt : 20061018 0001324517-06-000075.hdr.sgml : 20061018 20061018182214 ACCESSION NUMBER: 0001324517-06-000075 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061016 FILED AS OF DATE: 20061018 DATE AS OF CHANGE: 20061018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 CHIPETA WAY STE 240 CITY: SALT LAKE CITY STATE: UT ZIP: 84108-1256 BUSINESS PHONE: 8015834939 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Selisker Rachel R CENTRAL INDEX KEY: 0001313793 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 061151744 BUSINESS ADDRESS: BUSINESS PHONE: 801-583-4939 MAIL ADDRESS: STREET 1: 383 COLOROW DRIVE CITY: SALT LAKE CITY STATE: UT ZIP: 84108 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2006-10-16 0000890465 NPS PHARMACEUTICALS INC NPSP 0001313793 Selisker Rachel R 383 COLOROW DRIVE SALT LAKE CITY UT 84108 1 0 0 0 Deferred Stock Units 2006-10-16 4 A 0 4972 0 A Common Stock 4972 37880 D Each Deferred Stock Unit represents a right to receive one share of NPS Common Stock. Deferred Stock Units awarded under the Nonemployee Directors' Deferred Compensation Program will be settled in NPS Common Stock upon (1) separation from service on the Board, (2) death, (3) disability, or (4) sale of substantially all the assets of the Company. Val R. Antczak 2006-10-18 -----END PRIVACY-ENHANCED MESSAGE-----